Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ONVO

ONVO - Organovo Holdings Inc Stock Price, Fair Value and News

$0.36-0.01 (-2.70%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

ONVO Price Action

Last 7 days

-10%

Last 30 days

2.9%

Last 90 days

-28.0%

Trailing 12 Months

-67.6%

ONVO RSI Chart

ONVO Valuation

Market Cap

5.5M

Price/Earnings (Trailing)

-0.44

Price/Sales (Trailing)

53.71

EV/EBITDA

13.06

Price/Free Cashflow

-0.47

ONVO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ONVO Fundamentals

ONVO Revenue

Revenue (TTM)

103.0K

ONVO Earnings

Earnings (TTM)

-12.5M

Earnings Growth (Yr)

36.18%

Earnings Growth (Qtr)

23.77%

ONVO Profitability

Operating Margin

-1310.96%

EBT Margin

-167.81%

Return on Equity

-340.82%

Return on Assets

-185.7%

Free Cashflow Yield

-213.88%

ONVO Investor Care

Shares Dilution (1Y)

73.88%

Diluted EPS (TTM)

-1.05

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024109.0K73.0K103.0K0
2023370.0K445.0K368.0K242.0K
20221.8M01.1M746.7K
20202.2M000
20193.1M3.1M3.4M2.9M
20184.6M4.3M3.9M3.5M
20174.2M4.3M4.3M4.3M
20161.5M2.1M3.1M4.0M
2015571.0K778.0K1.0M1.2M
2014379.0K372.0K399.0K419.0K
20131.3M1.1M693.0K479.0K
2012564.9K650.6K887.6K1.2M
2011513.3K423.6K631.7K645.7K
2010000603.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About Organovo Holdings Inc

ONVO
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.
 WEBSITEorganovo.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES23

Organovo Holdings Inc Frequently Asked Questions

What is the ticker symbol for Organovo Holdings Inc? What does ONVO stand for in stocks?

ONVO is the stock ticker symbol of Organovo Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Organovo Holdings Inc (ONVO)?

As of Fri Dec 20 2024, market cap of Organovo Holdings Inc is 5.53 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ONVO stock?

You can check ONVO's fair value in chart for subscribers.

Is Organovo Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether ONVO is over valued or under valued. Whether Organovo Holdings Inc is cheap or expensive depends on the assumptions which impact Organovo Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ONVO.

What is Organovo Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, ONVO's PE ratio (Price to Earnings) is -0.44 and Price to Sales (PS) ratio is 53.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ONVO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Organovo Holdings Inc's stock?

In the past 10 years, Organovo Holdings Inc has provided -0.448 (multiply by 100 for percentage) rate of return.